financetom
Business
financetom
/
Business
/
Geopark Q1 Earnings Rise, Revenue Falls; Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Geopark Q1 Earnings Rise, Revenue Falls; Shares Drop After Hours
May 15, 2024 2:50 PM

05:38 PM EDT, 05/15/2024 (MT Newswires) -- Geopark ( GPRK ) reported Q1 earnings late Wednesday of $0.54 per diluted share, up from $0.45 a year earlier.

A single analyst polled by Capital IQ expected $0.59.

Revenue in the quarter ended March 31 fell to $167.4 million from $182.5 million a year earlier.

Two analysts surveyed by Capital IQ expected $193 million.

The company's shares fell 2.4% in after-hours activity.

Price: 9.65, Change: -0.24, Percent Change: -2.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Melcor REIT Concludes 'Go Shop' Period and Sells Grande Prairie Property in Alberta
Melcor REIT Concludes 'Go Shop' Period and Sells Grande Prairie Property in Alberta
Feb 25, 2025
09:56 AM EST, 02/25/2025 (MT Newswires) -- Melcor Real Estate Investment Trust (MR-UN.TO) on Tuesday said the 90 day go-shop period provided as part of a previously announced agreement expired without the arrival of a superior offer. As part of the deal, Melcor Developments ( MODVF ) will buy the 45% it doesn't already own of Melcor REIT LP for...
Precigen Says FDA Accepts for Priority Review Application for Recurrent Respiratory Papillomatosis Treatment
Precigen Says FDA Accepts for Priority Review Application for Recurrent Respiratory Papillomatosis Treatment
Feb 25, 2025
09:56 AM EST, 02/25/2025 (MT Newswires) -- Precigen ( PGEN ) said Tuesday that a biologics license application for PRGN-2012, an investigational gene therapy for the treatment of adults with recurrent respiratory papillomatosis, was accepted by the US Food and Drug Administration for priority review. The agency set a target action date of Aug. 27 and said that it is...
Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements
Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements
Feb 25, 2025
09:53 AM EST, 02/25/2025 (MT Newswires) -- Natera ( NTRA ) said Tuesday that its Signatera test for patients diagnosed with lung cancer has met coverage requirements for the Centers for Medicare & Medicaid Services' Molecular Diagnostics Services Program. The company said the coverage is intended for patients with non-small cell lung cancer, specifically patients with stage 1 through stage...
Soccer-Lack of success a key factor in Man Utd's financial troubles, says Amorim
Soccer-Lack of success a key factor in Man Utd's financial troubles, says Amorim
Feb 25, 2025
Feb 25 (Reuters) - Manchester United's ( MANU ) lack of success in recent years is a contributing factor in the Premier League club's financial struggles, manager Ruben Amorim said on Tuesday, stressing the importance of quickly improving performances on the pitch. On Monday, United announced they would cut 150-200 jobs as part of an overhaul to return to profitability...
Copyright 2023-2026 - www.financetom.com All Rights Reserved